Evidence map›Paper›PMID 24316783›Full record

ArticleNorth Carolina medical journal

Gene therapy: the promise of a permanent cure.

Christopher D Porada, Christopher Stem, Graca Almeida-Porada

Open access · greenAbstract read
In one paragraph

Article in North Carolina medical journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Christopher D PoradaWake Forest Institute for Regenerative Medicine, 391 Technology Way, Winston-Salem, NC 27157, USA. cporada@wakehealth.edu.
Christopher Stem
Graca Almeida-Porada
Wake Forest University · US

Funding

Prenatal Cell and Gene Therapy for Hemophilia AR01HL135853 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ALMEIDA-PORADA, GRACA DUARTE, PORADA, CHRISTOPHER D · 2017 to 2020
$2.8M
Postnatal Cell-Based Therapies for Hemophilia AR01HL130856 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ALMEIDA-PORADA, GRACA DUARTE, PORADA, CHRISTOPHER D · 2016 to 2019
$2.5M
NHLBI NIH HHS R01 HL130856NHLBI NIH HHS R01 HL135853
6 · The paper itself

Abstract

Gene therapy offers the possibility of a permanent cure for any of the more than 10,000 human diseases caused by a defect in a single gene. Among these diseases, the hemophilias represent an ideal target, and studies in both animals and humans have provided evidence that a permanent cure for hemophilia is within reach.

Indexed as

Genetic TherapyHemophilia AHumans

Identifiers

PMID24316783
PMCPMC8092353
OpenAlexW13881937

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.